MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ARDX made $94,473K in revenue. -$37,927K in net income. Net profit margin of -40.15%.

Income Overview

Revenue
$94,473K
Net Income
-$37,927K
Net Profit Margin
-40.15%
EPS
-$0.15
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Non Cash Royalty Related To Sale...
    • Product Supply Revenue
    • License
Revenue Breakdown
    • Product
    • Product And Service Other

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
94,473 125,215 110,329 97,662
Product
--2,662 -
Product And Service Other
--1,320 -
Cost of sales
4,811 10,849 3,982 12,403
Research and development
20,188 22,856 18,067 15,666
Selling, general and administrative
102,267 86,411 83,612 83,988
Total costs and operating expenses
127,266 148,804 101,679 99,654
Gain from operations
-32,793 5,099 4,668 -14,395
Interest expense
5,599 5,759 5,796 4,356
Non-cash interest expense related to the sale of future royalties
1,317 1,818 2,188 2,219
Other income, net
2,112 2,078 2,449 1,892
Loss before provision for income taxes
-37,597 -400 -867 -19,078
Provision for income taxes
8 7 102 1
Net loss
-37,605 -407 -969 -19,079
Unrealized losses on available-for-sale securities
-322 74 162 -56
Comprehensive loss
-37,927 -333 -807 -19,135
Basic EPS
-0.15 -0.001 0 -0.08
Diluted EPS
-0.15 -0.001 0 -0.08
Basic Average Shares
245,855,082 243,673,878 241,908,407 239,928,570
Diluted Average Shares
245,855,082 243,673,878 241,908,407 239,928,570
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$37,927K (7.91%↑ Y/Y)Net loss-$37,605K (8.60%↑ Y/Y)Unrealized losses onavailable-for-sale securities-$322K (-725.64%↓ Y/Y)Product IBSRELA$70,074K Product XPHOZAH$23,299K License AgreementDevelopment...$352K Kyowa KirinCo.Ltd-License Agreement...$2K Knight TherapeuticsInc-License Agreement...$31K License AgreementDevelopment...$20K Loss beforeprovision for income taxes-$37,597K (6.67%↑ Y/Y)Provision for income taxes$8K (-99.07%↓ Y/Y)Other income, net$2,112K (-9.20%↓ Y/Y)Product$93,373K (37.69%↑ Y/Y)Non Cash RoyaltyRelated To Sale Of Future...$695K (-32.26%↓ Y/Y)Product Supply Revenue$354K (39.37%↑ Y/Y)License$51K (-98.98%↓ Y/Y)Gain from operations-$32,793K (9.78%↑ Y/Y)Interest expense$5,599K (33.60%↑ Y/Y)Total revenues$94,473K (27.47%↑ Y/Y)Non-cash interestexpense related to the...$1,317K (-36.41%↓ Y/Y)Total costs andoperating expenses$127,266K (29.65%↑ Y/Y)Selling, general andadministrative$102,267K (22.88%↑ Y/Y)Research and development$20,188K (35.15%↑ Y/Y)Cost of sales$4,811K (-60.90%↓ Y/Y)

ARDELYX, INC. (ARDX)

ARDELYX, INC. (ARDX)